Concepedia

Short-Term Changes in Left and Right Systolic Function Following Ferric Carboxymaltose: A Substudy of the Myocardial-IRON Trial

Enrique Santas, Gema Miñana, Ingrid Cardells, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Luís Almenar, María P. López‐Lereu, José V. Monmeneu, Juan Sanchís,

ESC Heart Failure · 2020 · 25 citations · 24 references

Open access

Abstract

In patients with HF and systolic dysfunction with ID, FCM was associated with short-term improvement in LVEF and, especially, in RVEF.

References

24

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

PubMed · 2021 · 19.5K citations

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker et al. · European Journal of Heart Failure · 2016 · 5.8K citations · Full text

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Stefan D. Anker, Josep Comín Colet, Gerasimos Filippatos et al. · New England Journal of Medicine · 2009 · 2K citations · Full text

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

Piotr Ponikowski, Dirk J. van Veldhuisen, Josep Comín‐Colet et al. · European Heart Journal · 2014 · 1.2K citations · Full text

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable?

Nick G. Bellenger · European Heart Journal · 2000 · 1K citations · Full text